Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Riluzole exhibits cardioprotective activity in vivo

Aug. 17, 2010

FT-23 attenuates diastolic dysfunction in model of diabetic cardiomyopathy

Aug. 16, 2010

Iontophoretically delivered terbinafine enters phase II trial in onychomycosis

Aug. 16, 2010

Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis

Aug. 16, 2010

Onabotulinumtoxin A is safe and efficacious in women with vertical lip columns

Aug. 13, 2010

New clindamycin/tretinoin gel more effective than constituents in treating acne

Aug. 13, 2010

Cannabinoids show promise in models of inflammation and bone loss

Aug. 13, 2010

Abobotulinumtoxin A rapidly reduces glabellar lines in phase III trials

Aug. 13, 2010

Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis

Aug. 13, 2010

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Aug. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...